Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Biliary Tract Cancer × Cryosurgery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Cholangiocarcinoma 3 Sarcoma 2 Osteosarcoma 2 Melanoma 2 Liver Neoplasms 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Unresectable Solid Tumors 1 Solid Tumor, Adult 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma Locally Advanced 1 Neuroblastoma 1 Lung Neoplasms 1 Liver Metastasis 1 High-Burden Metastatic Solid Tumors 1 Hepatoblastoma 1 Gastric Cancer Metastatic to Liver 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Desmoid Tumors 1 Colonic Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1

Interventions

lenvatinib 3 tislelizumab 2 pembrolizumab 2 Gemcitabine 2 Cisplatin 2 toripalimab 1 theasinensin A 1 surufatinib 1 sitravatinib 1 sintilimab 1 durvalumab 1 S 1 (combination) 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05781074 2023-03-24

CASTLE-08

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡